Ferumoxytol is an intravenous iron oxide nanoparticle formulation that has been approved
by the US Food and Drug Administration (FDA) for treating anemia in patients with chronic …

Over the past decades, MRI has become increasingly important for diagnosing and
longitudinally monitoring musculoskeletal disorders, with ongoing hardware and software …

Metastatic osteosarcoma has a poor prognosis with a 2-y, event-free survival rate of∼ 15 to
20%, highlighting the need for the advancement of efficacious therapeutics. Chimeric …

Labeling stem cells with magnetic nanoparticles is a promising technique for in vivo tracking
and magnetic targeting of transplanted stem cells, which is critical for improving the …

Magnetic particle imaging (MPI) is a novel emerging noninvasive and radiation-free imaging
modality that can quantify superparamagnetic iron oxide nanoparticles tracers. The zero …

The continuous or real-time tracking of biological processes using biocompatible contrast
agents over a certain period of time is vital for precise diagnosis and treatment, such as …

Ferumoxytol, approved by the US Food and Drug Administration in 2009, is one of the
intravenous iron oxide nanoparticles authorized for the treatment of iron deficiency in …

Contrast-enhanced magnetic resonance imaging (CE-MRI) is a pivotal tool for global
disease diagnosis and management. Since its clinical availability in 2009, the off-label use …

The drive to develop cartilage implants for the treatment of major defects in the
musculoskeletal system has resulted in a major research thrust towards develo** …

The paracrine signaling, immunogenic properties and possible applications of
mesenchymal stromal cells (MSCs) for cartilage tissue engineering and regenerative …